We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current NFX market cap is 1.53M. The company's latest EPS is GBP -0.0012 and P/E is -1.67.
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 610k | 535k | 196k | 50k | 0 |
| Operating Income | -1.81M | -914k | -1.37M | -1.27M | -892k |
| Net Income | -1.66M | -756k | -1.25M | -1.11M | -859k |
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 4.64M | 5.13M | 6.01M | 4.98M | 4.42M |
| Total Liabilities | 820k | 383k | 325k | 238k | 223k |
| Total Equity | 3.82M | 4.74M | 5.69M | 4.74M | 4.2M |
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -299k | -718k | -845k | -1.35M | -596k |
| Investing | -27k | -43k | 43k | N/A | 50k |
| Financing | -7k | 1.3M | 1.93M | 140k | 285k |
| Market Cap | 1.53M |
| Price to Earnings Ratio | -1.67 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 6.67 |
| Price to Book Ratio | 0.35 |
| Dividend Yield | - |
| Shares Outstanding | 744.31M |
| Average Volume (1 week) | 313.55k |
| Average Volume (1 Month) | 1.89M |
| 52 Week Change | -18.00% |
| 52 Week High | 0.44 |
| 52 Week Low | 0.19 |
| Spread (Intraday) | 0.05 (21.74%) |
| Company Name | Nuformix Plc |
| Address |
6th floor london EC3V 0HR |
| Website | https://www.nuformix.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
